why am i not losing weight on tirzepatide 5 mg Mounjaro? Not Losing on Tirzepitide 5

Wegovy must be used for the following FDA-approved indications to get Aetna coverage: Use the medication along with a reduced-calorie diet and increased physical activity: To lower the risk of serious cardiovascular events (such as death from cardiovascular disease, non-fatal heart attack, or non-fatal stroke) in adults who have existing heart disease and are either overweight or obese

Since 2011, GoodRx has helped Americans save over $85 billion on the cost of their medications

In the U.S., they are not FDA-approved for human use but are available for research purposes

After discussing with my doctor about trying semaglutide, I met with Michele, the nurse practitioner at Viva Skin Lounge in March

Initially, researchers focused on Glucagon-like peptide-1 (GLP-1) as the primary target for regulating glucose-dependent insulin secretion

Quick Answer: Tirzepatide may not work effectively due to inadequate dosing, poor medication adherence, advanced beta-cell dysfunction, severe insulin resistance, improper injection technique, or unrealistic expectations about treatment timelines and outcomes